The 7investing Podcast
A podcast by 7investing
477 Episodes
-
7investing Explains: How are Medical Devices and Genetic Tests Regulated?
Published: 1/25/2022 -
Welcome Luke Hallard to 7investing!
Published: 1/20/2022 -
Why Have Growth Stocks Plummeted? An Interview with Tobias Carlisle
Published: 1/18/2022 -
5 Big Reveals from the 2022 JP Morgan Healthcare Conference
Published: 1/13/2022 -
Improving Your Decision-Making Process with Krzysztof Piekarski
Published: 1/11/2022 -
Buy Castlight Health: A 7investing Deep Dive
Published: 1/6/2022 -
Navigating Market Volatility with ChitChatMoney's Ryan Henderson and Brett Schafer
Published: 1/4/2022 -
Buy Dicerna Pharmaceuticals: A 7investing Deep Dive
Published: 12/29/2021 -
Investing in Emerging Markets with Perth Tolle
Published: 12/16/2021 -
The Power of Investing Young with Maya and Soren Peterson
Published: 12/9/2021 -
What's Next for Synthetic Biology?
Published: 11/30/2021 -
Digital Advertising's New Future with PubMatic CEO Rajeev Goel
Published: 11/18/2021 -
Tesla and Technical Analysis with O'Neil Advisors' Irusha Peiris
Published: 11/11/2021 -
A CEO's Perspective of Investing in Biotechs with Al Altomari, CEO of Agile Therapeutics
Published: 11/9/2021 -
Is Peloton a Good Investment?
Published: 11/9/2021 -
Zillow Drops iBuying; What’s a Metaverse?
Published: 11/5/2021 -
Investing in Environmental, Social, and Governance with Corbin Advisors SVP Robert McConnaughey
Published: 11/4/2021 -
Apple Results, Amazon, Microsoft, Google, and the Cloud
Published: 11/3/2021 -
What Does the Future of Sports Betting Look Like in the U.S.?
Published: 10/27/2021 -
Is it too Late to Buy Tesla?
Published: 10/25/2021
Welcome to 7investing.com. Our mission is to empower you to invest in your future. This podcast brings our market-based experts together to discuss our investing process and important news. Once a month, we will also feature interviews with some of the best minds in business and investing. Check out 7investing.com to find more of our free content and premium monthly stock recommendations.